跳至主要内容
临床试验/NCT04714502
NCT04714502Unknown不适用

Verification of Biomarkers to Examine Neonatal Asphyxia-induced Hypoxic-ischemic Encephalopathy Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test

InfanDx AG4 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2019年7月2日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
144
试验地点
4
主要终点
Participants with abnormal neuro-developmental status - non-HIE

研究概览

简要总结

Follow-up of participants of AAMBI1 study at age of at least 2 years. AAMBI1(ClinicalTrials.gov ID: NCT03354208): Verification of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies.

详细描述

Follow-Up on neuro-developmental status of Study participants of AAMBI1. AAMBI1(ClinicalTrials.gov ID: NCT03354208): The aim of the study is to verify the application of combinations of several laboratory parameters in early postnatal blood samples, for identification of infants, who will suffer from early abnormal neonatal neurological outcome, in a population at risk. The population at risk is defined as term and late preterm (>36 weeks of gestation) human infants following perinatal hypoxia-ischemia with or without postnatal resuscitation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Months 至 48 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Infants previously enrolled in the AAMBI1 study

排除标准

  • Missing valid written informed parental consent

结局指标

主要结局

Participants with abnormal neuro-developmental status - non-HIE

时间窗: up to 42 month age

Presence of adverse 2 years neuro-developmental Outcome not attributable to perinatal hypoxic-ischemic brain injury

Participants with normal neuro-developmental status

时间窗: up to 42 month age

All infants with normal neuro-developmental status

Participants with abnormal neuro-developmental status - HIE

时间窗: up to 42 month age

Presence of adverse 2 years neuro-developmental outcome likely attributable to perinatal hypoxic-ischemic brain injury

Participants with potentially abnormal neuro-developmental status

时间窗: up to 42 month age

All infants who do not fulfill outcomes 1, 3 or 4

次要结局

未报告次要终点

研究者

发起方
InfanDx AG
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验